2007
DOI: 10.1016/j.freeradbiomed.2006.12.021
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian cancer cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

9
301
1
3

Year Published

2010
2010
2022
2022

Publication Types

Select...
4
4

Relationship

2
6

Authors

Journals

citations
Cited by 371 publications
(314 citation statements)
references
References 47 publications
9
301
1
3
Order By: Relevance
“…However, very recently, additional in vitro studies indicated that auranofin is able to overcome cisplatin resistance in human 4 ovarian cancer cells [9], confirming the earlier assumption that a mechanism of action different from the recognized DNA damage induced by cisplatin could underlie the cytotoxic activity of phosphine Au(I) drugs. In particular, it was found that auranofin, acting as a potent inhibitor of thioredoxin reductase, causes an alteration of the redox state of the cell leading to an increased production of hydrogen peroxide and oxidation of the components of the thioredoxin (Trx) system, therefore creating the conditions for enhanced apoptosis [9].…”
Section: Introductionsupporting
confidence: 60%
“…However, very recently, additional in vitro studies indicated that auranofin is able to overcome cisplatin resistance in human 4 ovarian cancer cells [9], confirming the earlier assumption that a mechanism of action different from the recognized DNA damage induced by cisplatin could underlie the cytotoxic activity of phosphine Au(I) drugs. In particular, it was found that auranofin, acting as a potent inhibitor of thioredoxin reductase, causes an alteration of the redox state of the cell leading to an increased production of hydrogen peroxide and oxidation of the components of the thioredoxin (Trx) system, therefore creating the conditions for enhanced apoptosis [9].…”
Section: Introductionsupporting
confidence: 60%
“…The behavior of Auoxo6 is compared with that of auranofin, a gold(I) antiarthritic drug, endowed with significant cytotoxic properties in vitro (but not in vivo) [7]. Auranofin was chosen as a control compound since it is a typical gold(I) drug in clinical use and a lot is known about its biochemical effects at the cellular level [8,9]. The chemical structures of Auoxo6 and auranofin are shown in Fig.…”
Section: Introductionmentioning
confidence: 99%
“…IC 50 values represent the drug concentrations that reduced the mean absorbance at 570 nm to 50% of those in the untreated control wells. The condensation reaction, carried out in DMF solution was monitored by 31 P NMR spectroscopy showing that, at room temperature, a complex mixture of products is formed. At 70°C, in a few days, it converts quantitatively into the trinuclear species 1 characterized by two AB multiplets, having relative intensities of 2:1, at δ −27.01 ( 1 J PPt = 3126 Hz), 28.31 (3234 Hz) at δ −27.14 ( 1 J PPt = 3126 Hz), 28.58 (3234 Hz, with 2 J PP =24.8 Hz) ppm, respectively.…”
Section: Cytotoxicity Assaysmentioning
confidence: 99%
“…The presence of two sets of signals for the nucleoside is in line with the existence of two conformers resulting in the relative orientation, syn and anti, of the ribose groups with respect to the pyrimidinic ring. The reaction of the hydroxo complex with the bulkier PPh 3 ligands, was carried out in DMF or CH 2 Cl 2 /MeOH solution and monitored by 31 P NMR spectroscopy. In both cases, complex 4 was formed in high yield (N80%).…”
Section: Cytotoxicity Assaysmentioning
confidence: 99%
See 1 more Smart Citation